RayanaAI
Account
DHR
BUYTrend
Composite
67.70
Technical
86.30
Fundamental
44.90
Rank
—
Price
236.98
Hurst
0.61
As of
Oct 30, 2026
Daily
Danaher Corporation
HealthcareDiagnostics & Research

Danaher Corporation manufactures and sells equipment, instruments, software, and supplies for biotechnology, life sciences, and diagnostics applications across global markets. The company's biotechnology segment serves pharmaceutical manufacturing with process technologies, media, filtration systems, and single-use manufacturing solutions. Its life sciences segment offers analytical instruments including mass spectrometers, flow cytometers, microscopes, and genomic products under brands such as Beckman Coulter, Leica Microsystems, and IDT. The diagnostics segment provides clinical testing instruments and software used by hospitals, laboratories, and healthcare facilities to identify diseases and guide treatment decisions.

Market cap
$163.3B
P/E (trailing)
38.45
P/E (forward)
24.92
PEG ratio
1.32
Dividend yield
69.00%
Beta
0.80
52w range
160.93 – 242.80
Return on equity
+8.19%
Profit margin
+16.91%
Revenue growth
+8.30%
Earnings growth
+37.80%
Price history

1Y: 232.23 (+8.6%) · range 161.29–240.61

Cycle position
66/ 100 cycle scoreAPPROACHING EXIT
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT

entry readiness 11 · NOT READY · exit proximity 0

Conviction
25/ 100 · maturity 100%
VScore.4020
Buildup.2036
EMA entry setup.2511
Fundamentals.1545
Volume profile
POC
201.56
Price vs POC
+17.6%
Overhead supply
0%
Runway
open sky

Value area 183.66–233.46 · 0% of 120d volume overhead · clean runway

Contributing sources
SourceScoreLast seen
earnings-surprise
0.462
Oct 30, 2026
Pattern & cluster
Pattern
NEUTRAL
Cluster
CONFIRM
Forward returns
HorizonReturnMFEState
20d+0.33%+0.33%1/20d
40d+0.33%+0.33%1/40d